Search results

21 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Costs for orally-administered cancer drugs skyrocket
A study, authored by UNC Lineberger member Stacie Dusetzina, PhD, found that oral cancer drugs introduced in 2014 were, on average, six times more expensive than those introduced in the year 2000. The findings, published in JAMA Oncology, raised concerns as patients may increasingly take on the cost burden of those increases.
Located in News
UNC-Chapel Hill researchers to launch cancer nanotechnology training program
The university has received a grant from the National Institutes of Health to create a postdoctoral training program in cancer nanotechnology within the UNC Eshelman School of Pharmacy.
Located in News
UNC Lineberger members go to Washington to highlight importance of research funding
Chad Ellis, PhD, Ben Major, PhD, and Anne-Marie Meyer, PhD, traveled to the U.S. Capitol to meet with members of the North Carolina congressional delegation and explain the impact of National Institutes of Health and National Cancer Institute funding on the lives and well-being of people in North Carolina and the country.
Located in News
UNC Lineberger, NCCU awarded grants for cancer research partnership
UNC Lineberger and North Carolina Central University were awarded grants totaling more than $11 million for cancer research that addresses disparities in cancer incidence and death for African-Americans in North Carolina.
Located in News
UNC School of Medicine Names Inaugural Yang Family Biomedical Scholars
The award, made possible through a donation from Lenovo chairman and CEO Yuanqing Yang, recognizes the research achievements of young tenured faculty.
Located in News
UNC Lineberger-led study finds higher vitamin D and calcium intake does not reduce colorectal polyp risk
A UNC Lineberger-led study published in the New England Journal of Medicine found that vitamin D and calcium supplements do not reduce the risk of colorectal adenomas, which are benign tumors that can evolve into colorectal cancer.
Located in News
Subgroup of women with HER-2-positive breast cancer highly sensitive to treatments, study finds
A UNC Lineberger-led study published in the Journal of Clinical Oncology identified a group of women with HER2 positive breast cancer who could benefit from less intensive targeted treatment
Located in News
Study by UNC Lineberger scientist details role of tumor suppressor
UNC Lineberger Comprehensive Cancer Center researchers are working to better understand the cell-to-cell signaling that can cause precancerous polyps in the colon when signaling goes awry. In a study published in the open-access journal eLife, they describe the role of a key tumor suppressor protein called APC in helping to keep cells in the colon crypts from growing out of control.
Located in News
Mayer, Rimer named to Cancer 'Moonshot' Blue Ribbon Panel
Two UNC Lineberger Comprehensive Cancer Center members - Drs. Deborah Mayer and Barbara Rimer - have been honored with appointments to the National Cancer Moonshot Initiative's Blue Ribbon Panel. They will join a team of cancer experts to provide advice and vision in the implementation of the national program.
Located in News
Study finds sizeable minority of physicians do not strongly endorse HPV vaccine
Researchers surveyed more than 700 pediatricians and family physicians about their recommendations for the HPV vaccine, finding that 27 percent did not strongly endorse the vaccine. The findings are significant as low uptake of HPV vaccination is contributing to a national crisis in cancer prevention, said UNC Lineberger researcher and study senior author Noel Brewer.
Located in News